Gabelli & Co Investment Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,000
Closed -$237K 264
2023
Q4
$237K Hold
3,000
0.04% 165
2023
Q3
$209K Hold
3,000
0.03% 177
2023
Q2
$207K Hold
3,000
0.03% 175
2023
Q1
$223K Hold
3,000
0.04% 146
2022
Q4
$280K Hold
3,000
0.06% 160
2022
Q3
$286K Hold
3,000
0.04% 265
2022
Q2
$278K Hold
3,000
0.04% 287
2022
Q1
$304K Hold
3,000
0.04% 287
2021
Q4
$309K Sell
3,000
-116
-4% -$10.7K 0.04% 293
2021
Q3
$264K Hold
3,116
0.03% 296
2021
Q2
$260K Sell
3,116
-1,534
-33% -$126K 0.03% 286
2021
Q1
$350K Buy
4,650
+1,000
+27% +$72.8K 0.04% 261
2020
Q4
$249K Buy
3,650
+150
+4% +$9.76K 0.04% 233
2020
Q3
$204K Hold
3,500
0.04% 180
2020
Q2
$227K Hold
3,500
0.05% 144
2020
Q1
$208K Buy
3,500
+500
+17% +$33.4K 0.03% 144
2019
Q4
$223K Buy
+3,000
New +$211K 0.03% 157
2016
Q4
Sell
-3,000
Closed -$267K 156
2016
Q3
$267K Hold
3,000
0.03% 135
2016
Q2
$287K Hold
3,000
0.04% 141
2016
Q1
$311K Hold
3,000
0.04% 130
2015
Q4
$293K Hold
3,000
0.03% 144
2015
Q3
$289K Buy
3,000
+500
+20% +$52.6K 0.04% 137
2015
Q2
$262K Buy
+2,500
New +$255K 0.04% 142

Other funds holding CVS

Gabelli & Co Investment Advisers's CVS Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,000 shares — an estimated $237K sold.

Gabelli & Co Investment Advisers first reported a position in CVS in Q2 2015 and held it in 23 quarters. The position peaked at $350K in Q1 2021. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Gabelli & Co Investment Advisers reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 3,000 CVS Health shares in Q1 2024, an estimated $237K.
  • Gabelli & Co Investment Advisers first reported a position in CVS Health in Q2 2015 and held it in 23 quarters.
  • Gabelli & Co Investment Advisers's CVS Health position peaked at $350K in Q1 2021.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.